Hippocratic AI Secures $126 Million in Funding, Valued at $3.5 Billion, as Healthcare AI Unicorns Accelerate

On Nov. 3, U.S. generative AI healthcare unicornsHippocratic AIannounced the completion of a $126 million (roughly Rs. 897 million) Series Cfinancing, with participation from CapitalG, an independent growth fund of Google's parent company Alphabet. The round also valued the company at $3.5 billion (roughly Rs. 24.924 billion), bringing the total funding to $404 million (roughly Rs. 2.877 billion).

It also means that Hippocratic AI's valuation has more than doubled in less than a year since the company closed its Series B funding round in January this year at a valuation of $1.64 billion (roughly Rs. 11.678 billion).

Hippocratic AI's latest round of funding will be used for mergers and acquisitions, product development and expanding its international presence to fuel the company's expansion.

Founded in early 2023, Hippocratic AI focuses on AI healthcare and was founded by current CEO Munjal Shah in conjunction with a number of physicians, hospital administrators, healthcare professionals, and AI researchers, healthcare and AI workers from El Camino Hospital, Johns Hopkins University, Washington University in St. Louis, Stanford University , Microsoft, Google and NVIDIA.

▲Hippocratic AI team (Source: social media platform X)

Previously, Hippocratic AI had received $53 million (roughly Rs. 377 million) in Series A funding in March 2024, and an additional $17 million (roughly Rs. 121 million) in Series A expansion funding in September 2024, primarily from NVentures, the venture capital arm of NVIDIA, and in January 2025, the company received $141 million (approximately RMB 1,004 million) in Series B financing, with NVIDIA again participating, valuing the company at US$1.64 billion.

Hippocratic AI's core product is its self-developed Polaris architecture. This architecture is used to build a wide range of generative AI healthcare Agents to enable real-time conversations between patients and AI and to undertake non-diagnostic, patient-facing interaction tasks. In March of this year, Hippocratic AI launched its latest underlying model architecture, Polaris 3.0, which consists of 22 large models and 4.2 trillion parameters, with powerful audio processing and multilingual language recognition capabilities, and a health risk assessment accuracy rate of up to 98.51 TP4T.

▲Polaris architecture (Source: Hippocratic AI)

Hippocratic AI says its product is centered on safety, which has been tested not only with 500,000 test calls with more than 7,000 U.S.-licensed clinicians, but also with more than 115 million cross-validated simulations of clinical patient records.

Currently, the company has launched more than 1,000 AI healthcare Agents for a variety of areas, including nursing, readmission prevention, and health equity, and has partnerships with more than 50 healthcare organizations, including Cleveland Clinic, Northwestern Medicine, and Ochsner Health.

▲Healthcare Agent launched by Hippocratic AI (Source: Hippocratic AI)

According to Dimitri Zabelin, Senior AI Analyst at PitchBook, a leading global investment tracker, “Hippocratic AI's valuation has nearly doubled in less than a year, driven by partnerships with over 50 healthcare organizations, reflecting its commercial attractiveness and market fit. ”

According to Oliver Rhine, Global Chief Strategy Officer and President of Cincinnati Children's Hospital, an investor in the financing, “Hippocratic AI's focus on safety and scale coincides with Cincinnati's vision of delivering high-quality pediatric care to its customers. The AI assistant helps Cincinnati support its clients in a warmer and more precise way when it comes to scheduling, chronic disease management and daily guidance.” Cincinnati Children's is also a longtime Hippocratic AI partner.

Conclusion:Hippocratic AI doubles in valuation as competition in AI healthcare track escalates

Julie Yoo, a general partner at investor Andreessen Horowitz (a16z), said in a statement, “The rapid growth of Hippocratic AI is proof that the market needs a solution to the supply/demand imbalance between doctors and patients.”

Global venture capital investments totaled $97 billion in the third quarter of this year, of which, 46% went to AI companies. After the new financing, the valuation of Hippocratic AI has soared. NVIDIA and Google have bet on the AI medical track one after another, and more and more players are entering the game, as a patient-oriented rather than hospital-oriented Agent company, Hippocratic AI may face more intense market competition.

Source: Reuters